Počet záznamů: 1
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use
- 1.0541976 - ÚOCHB 2022 RIV eng P - Patentový dokument
Hocek, Michal - Tichý, Michal - Hajdúch, M. - Džubák, P.
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use.
2021. Vlastník: Ústav organické chemie a biochemie AV ČR, v. v. i. - Univerzita Palackého v Olomouci. Datum udělení patentu: 16.02.2021. Číslo patentu: CA3029170
Grant CEP: GA TA ČR(CZ) TE01020028; GA ČR(CZ) GA16-00178S; GA MZd(CZ) NV15-31984A
Institucionální podpora: RVO:61388963
Klíčová slova: nucleosides * fused heterocycles * cytostatics
Obor OECD: Medicinal chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20210216&DB=&locale=en_EP&CC=CA&NR=3029170C&KC=C&ND=4
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use. The invention provides a new goup of substituted thienopyrrolopyrimidine ribonucleosides of general formula I, wherein R is defined in the claims. The compounds of this invention show strong cytostatic and cytotoxic activities preferably against cancer cell lines of broad spectrum of diseases including tumors of various histogenetic origin.
Trvalý link: http://hdl.handle.net/11104/0319485
Počet záznamů: 1